Pfizer, already flush with cash, will reap $16B from selling shares in GSK consumer health spinoff

Pfizer, already flush with cash, will reap $16B from selling shares in GSK consumer health spinoff
aliu
Wed, 06/01/2022 – 07:40



Source link